Chimeric Therapeutics Limited (ASX:CHM)
Australia · Delayed Price · Currency is AUD 0.1000
0.00 (0.00%)
May 29, 2026, 3:59 PM AEST
Chimeric Therapeutics Market Cap
Chimeric Therapeutics has a market cap or net worth of 5.32 million as of May 29, 2026. Its market cap has decreased by -51.23% in one year.
Market Cap
5.32M
Enterprise Value
2.81M
Revenue
9.75M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since January 18, 2021, Chimeric Therapeutics's market cap has decreased from 97.50M to 5.32M, a decrease of -94.55%. That is a compound annual growth rate of -41.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 5.32M | -35.28% |
| Dec 31, 2025 | 8.22M | -25.46% |
| Dec 31, 2024 | 11.02M | -56.60% |
| Dec 29, 2023 | 25.40M | -27.35% |
| Dec 30, 2022 | 34.97M | -59.93% |
| Dec 31, 2021 | 87.26M | -10.51% |
| Jan 18, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AdAlta | 11.95M |
| Cambium Bio | 11.89M |
| Bio-Gene Technology | 8.54M |
| Invex Therapeutics | 8.27M |
| Vectus Biosystems | 6.76M |
| Tissue Repair | 6.65M |
| Acrux | 6.16M |
| Zelira Therapeutics | 5.95M |